These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15721855)

  • 21. Alpha-Tocopherol and endothelial nitric oxide synthesis.
    Heller R; Werner-Felmayer G; Werner ER
    Ann N Y Acad Sci; 2004 Dec; 1031():74-85. PubMed ID: 15753135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects.
    Werner ER; Gorren AC; Heller R; Werner-Felmayer G; Mayer B
    Exp Biol Med (Maywood); 2003 Dec; 228(11):1291-302. PubMed ID: 14681545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.
    Wunderlich C; Schober K; Schmeisser A; Heerwagen C; Tausche AK; Steinbronn N; Brandt A; Kasper M; Schwencke C; Braun-Dullaeus RC; Strasser RH
    J Mol Cell Cardiol; 2008 May; 44(5):938-47. PubMed ID: 18417152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications.
    Vásquez-Vivar J; Kalyanaraman B; Martásek P
    Free Radic Res; 2003 Feb; 37(2):121-7. PubMed ID: 12653200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of high glucose on vasculature.
    Marfella R; Esposito K; Giugliano D
    Circulation; 2003 Sep; 108(10):e74; author reply e74. PubMed ID: 12963688
    [No Abstract]   [Full Text] [Related]  

  • 26. A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS.
    Triggle CR; Ding H
    J Am Soc Hypertens; 2010; 4(3):102-15. PubMed ID: 20470995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling.
    Wohlfart P; Xu H; Endlich A; Habermeier A; Closs EI; Hübschle T; Mang C; Strobel H; Suzuki T; Kleinert H; Förstermann U; Ruetten H; Li H
    J Pharmacol Exp Ther; 2008 May; 325(2):370-9. PubMed ID: 18252813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress disrupts nitric oxide synthase activation in liver endothelial cells.
    Karaa A; Kamoun WS; Clemens MG
    Free Radic Biol Med; 2005 Nov; 39(10):1320-31. PubMed ID: 16257641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
    Balakumar P; Chakkarwar VA; Krishan P; Singh M
    Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase.
    Kuzkaya N; Weissmann N; Harrison DG; Dikalov S
    Biochem Pharmacol; 2005 Aug; 70(3):343-54. PubMed ID: 15963955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction?
    Tiefenbacher CP
    Am J Physiol Heart Circ Physiol; 2001 Jun; 280(6):H2484-8. PubMed ID: 11356602
    [No Abstract]   [Full Text] [Related]  

  • 32. [NO and hypertension].
    Hirata Y
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():243-6. PubMed ID: 15171377
    [No Abstract]   [Full Text] [Related]  

  • 33. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells.
    Zhao X; Li X; Trusa S; Olson SC
    Regul Pept; 2005 Dec; 132(1-3):113-22. PubMed ID: 16242794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetrahydrobiopterin and cardiovascular disease.
    Moens AL; Kass DA
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2439-44. PubMed ID: 16946131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathogenesis and progression of neuropathies in diabetic patients with endothelial dysfunction].
    Naruse K; Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():516-20. PubMed ID: 15999762
    [No Abstract]   [Full Text] [Related]  

  • 36. A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression.
    Takaya T; Hirata K; Yamashita T; Shinohara M; Sasaki N; Inoue N; Yada T; Goto M; Fukatsu A; Hayashi T; Alp NJ; Channon KM; Yokoyama M; Kawashima S
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1632-7. PubMed ID: 17463333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial GTPCH in eNOS uncoupling and atherosclerosis.
    Fukai T
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1493-5. PubMed ID: 17581829
    [No Abstract]   [Full Text] [Related]  

  • 38. Nitric oxide and vascular insulin resistance.
    Wu G; Meininger CJ
    Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible impact of tetrahydrobiopterin and sepiapterin on endothelial dysfunction.
    Blau N; Thöny B
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):913-4; author reply 914-5. PubMed ID: 12740227
    [No Abstract]   [Full Text] [Related]  

  • 40. [Endothelial cell dysfunction diabetes mellitus--oxidative stress and cell injury].
    Kashiwagi A
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():216-24. PubMed ID: 12355750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.